WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Netherlands Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2015

Global Markets Direct, September 2009, Pages: 92

Netherlands Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Netherlands nephrology & urology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the nephrology & urology devices market in Netherlands

Scope

- The report provides information on the nephrology and urology devices market in Netherlands.
- Details on key segments and categories such as Incontinence Devices, Lithotripters, and Renal Dialysis Equipment.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors such as Svenska Celulosa Aktiebolaget SCA, Coloplast A/S, Fresenius Medical Care AG & Co. KGaA, Gambro AB, and Baxter International Inc.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the nephrology and urology devices market in Netherlands.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report
3.1 Nephrology and Urology Devices
3.2 Incontinence Devices
3.2.1 Protective garments for incontinence
3.2.2 Urine Bags
3.2.3 Urinary Catheters
3.3 Renal Dialysis Equipment
3.3.1 Hemodialysis Machines
3.3.2 Peritoneal Dialysis Solutions
3.3.3 Continuous Renal Replacement Therapy Machines
3.3.4 Dialysis Accessories
3.3.4.1 AV Fistula Needles
3.3.4.2 Blood Tubing Sets
3.3.4.3 Dialysis Catheters
3.3.4.4 Dialyzers
3.4 Lithotripters
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
4.3.1 Health Insurance Act
4.3.2 Healthcare Allowance Act
4.3.3 The Exceptional Medical Expenses Act
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification of Medical Devices
5.1.2 Conformity Assessment Process
5.1.2.1 Class I devices
5.1.2.2 Class IIa devices
5.1.2.3 Class IIb devices
5.1.2.4 Class III devices
5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
6.1 Pricing and Reimbursement in Netherlands
7 Distribution Structure
7.1 Distribution Structure in Netherlands
8 Nephrology and Urology Devices In Netherlands
8.1 Nephrology and Urology Devices, Netherlands, Overall Revenue ($ mn), 2000-2015
8.2 Nephrology and Urology Devices, Netherlands, Category Volume (Units), 2000-2015
8.3 Nephrology and Urology Devices, Netherlands, Company Share (2007-2008)
9 Incontinence Devices In Netherlands
9.1 Incontinence Devices Overall Revenue (2000-2015)
9.2 Incontinence Devices Overall Volume (2000-2015)
9.3 Incontinence Devices Average Price (2000-2015)
9.4 Incontinence Devices Distribution Share (2007-2008)
9.5 Incontinence Devices, Netherlands, Company Share (2007-2008)
10 Lithotripters In Netherlands
10.1 Lithotripters Overall Revenue (2000-2015)
10.2 Lithotripters Overall Volume (2000-2015)
10.3 Lithotripters Average Price (2000-2015)
10.4 Lithotripters Distribution Share (2007-2008)
10.5 Lithotripters, Netherlands, Company Share (2007-2008)
11 Renal Dialysis Equipment In Netherlands
11.1 Renal Dialysis Equipment Overall Revenue (2000-2015)
11.1.1 Dialysis Accessories Overall Revenue (2000-2015)
11.2 Renal Dialysis Equipment Overall Volume (2000-2015)
11.2.1 Dialysis Accessories Overall Volume (2000-2015)
11.3 Renal Dialysis Equipment Average Price (2000-2015)
11.4 Renal Dialysis Equipment Distribution Share (2007-2008)
11.5 Renal Dialysis Equipment, Netherlands, Company Share (2007-2008)
12 Overview of Key Companies in Netherlands Nephrology and Urology Devices Market
12.1 Svenska Celullosa Aktiebolaget SCA
12.1.1 Company Overview
12.2 Fresenius Medical Care AG & Co. KGaA
12.2.1 Company Overview
12.3 Gambro AB
12.3.1 Company Overview
12.3.2 Gambro AB Pipeline Products
12.3.2.1 Gambro AB Pipeline Products By Equipment Type
12.3.2.2 Gambro AB Pipeline Products By Development Stage
12.3.2.3 Gambro AB Pipeline Products By Therapy Area
12.3.2.4 Gambro AB Pipeline Products By Clinical Trials
12.4 Kimberly-Clark Corporation
12.4.1 Company Overview
12.5 HARTMANN GROUP
12.5.1 Company Overview
12.6 Coloplast A/S
12.6.1 Company Overview
12.7 Baxter International Inc.
12.7.1 Company Overview
12.7.2 Baxter International Inc. Pipeline Products
12.7.2.1 Baxter International Inc. Pipeline Products By Equipment Type
12.7.2.2 Baxter International Inc. Pipeline Products By Development Stage
12.7.2.3 Baxter International Inc. Pipeline Products By Therapy Area
12.7.2.4 Baxter International Inc. Pipeline Products By Clinical Trials
12.7.2.5 Baxter International Inc. Pipeline Products By News Summary
12.8 Teleflex Incorporated
12.8.1 Company Overview
12.9 STORZ MEDICAL AG
12.9.1 Company Overview
12.10 Siemens Healthcare
12.10.1 Company Overview
12.10.2 Siemens Medical Solutions Pipeline Products
12.10.2.1 Siemens Medical Solutions Pipeline Products By Equipment Type
12.10.2.2 Siemens Medical Solutions Pipeline Products By Development Stage
12.10.2.3 Siemens Medical Solutions Pipeline Products By Therapy Area
12.10.2.4 Siemens Medical Solutions Pipeline Products By Clinical Trials
12.10.2.5 Siemens Medical Solutions Pipeline Products By News Summary
12.11 ONTEX International N.V.
12.11.1 Company Overview
12.12 Dornier MedTech GmbH
12.12.1 Company Overview
12.13 Covidien Ltd.
12.13.1 Company Overview
12.14 C.R. Bard, Inc.
12.14.1 Company Overview
12.14.2 C.R. Bard, Inc. Pipeline Products
12.14.2.1 C.R. Bard, Inc. Pipeline Products By Equipment Type
12.14.2.2 C.R. Bard, Inc. Pipeline Products By Development Stage
12.14.2.3 C.R. Bard, Inc. Pipeline Products By Therapy Area
12.14.2.4 C.R. Bard, Inc. Pipeline Products By Clinical Trials
12.15 B. Braun Melsungen AG
12.15.1 Company Overview
12.16 AstraZeneca PLC
12.16.1 Company Overview
12.17 Medical Enterprises Europe B.V.
12.17.1 Company Overview
12.17.2 Medical Enterprises Europe B.V. Pipeline Products
12.17.2.1 Medical Enterprises Europe B.V. Pipeline Products By Equipment Type
12.17.2.2 Medical Enterprises Europe B.V. Pipeline Products By Development Stage
12.17.2.3 Medical Enterprises Europe B.V. Pipeline Products By Therapy Area
12.17.2.4 Medical Enterprises Europe B.V. Pipeline Products By Clinical Trials
13 Appendix
13.1 Global Markets Direct Research Methodology
13.2 Secondary Research
13.3 Primary Research
13.4 Models
13.5 Forecasts
13.6 Expert Panel Validation
13.7 Currency Conversion
13.8 Contact Us
13.9 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Healthcare Expenditure in Netherlands, 2000 - 2007 14
Table 2: Doctors by Specialty in Netherlands, 2000-2006 18
Table 3: Hospital Wards by Type in Netherlands, 2000-2006 19
Table 4: Nephrology and Urology Devices, Netherlands, Overall Revenue ($ mn), 2000-2015 36
Table 5: Nephrology and Urology Devices, Netherlands a, Cross-Category Analysis, 2000-2015 37
Table 6: Nephrology and Urology Devices, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008 38
Table 7: Nephrology and Urology Devices, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015 39
Table 8: Nephrology and Urology Devices, Netherlands, Category Volume (Units), 2000-2015 40
Table 9: Nephrology and Urology Devices, Netherlands, Category Volume (Units), Historic, 2000-2008 40
Table 10: Nephrology and Urology Devices, Netherlands, Category Volume (Units), Forecast, 2008-2015 41
Table 11: Nephrology and Urology Devices, Netherlands, Company Share by Revenue ($ mn), 2007-2008 42
Table 12: Incontinence Devices, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 43
Table 13: Incontinence Devices, Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015 44
Table 14: Incontinence Devices, Netherlands, Volume (Units) by Segment, Historic, 2000-2008 45
Table 15: Incontinence Devices, Netherlands, Volume (Units) by Segment, Forecast, 2008-2015 46
Table 16: Incontinence Devices, Netherlands, Average Price ($), Historic, 2000-2008 47
Table 17: Incontinence Devices, Netherlands, Average Price ($), Forecast, 2008-2015 47
Table 18: Incontinence Devices, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 48
Table 19: Incontinence Devices, Netherlands, Company Share by Revenue ($ mn), 2007-2008 50
Table 20: Lithotripters, Netherlands, Revenue ($ mn), Historic, 2000-2008 51
Table 21: Lithotripters, Netherlands, Revenue ($ mn), Forecast, 2008-2015 52
Table 22: Lithotripters, Netherlands, Volume (Units), Historic, 2000-2008 53
Table 23: Lithotripters, Netherlands, Volume (Units), Forecast, 2008-2015 54
Table 24: Lithotripters, Netherlands, Average Price ($), Historic, 2000-2008 55
Table 25: Lithotripters, Netherlands, Average Price ($), Forecast, 2008-2015 55
Table 26: Lithotripters, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 56
Table 27: Lithotripters, Netherlands, Company Share by Revenue ($ mn), 2007-2008 57
Table 28: Renal Dialysis Equipment, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 59
Table 29: Renal Dialysis Equipment, Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015 61
Table 30: Dialysis Accessories, Netherlands, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 62
Table 31: Dialysis Accessories, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 63
Table 32: Renal Dialysis Equipment, Netherlands, Volume (Units) by Segment, Historic, 2000-2008 64
Table 33: Renal Dialysis Equipment, Netherlands, Volume (Units) by Segment, Forecast, 2008-2015 64
Table 34: Dialysis Accessories, Netherlands, Volume (Units) by Sub-Segment, Historic, 2000-2008 65
Table 35: Dialysis Accessories, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2008-2015 66
Table 36: Renal Dialysis Equipment, Netherlands, Average Price ($), Historic, 2000-2008 67
Table 37: Renal Dialysis Equipment, Netherlands, Average Price ($), Forecast, 2008-2015 67
Table 38: Renal Dialysis Equipment, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 68
Table 39: Renal Dialysis Equipment, Netherlands, Company Share by Revenue ($ mn), 2007-2008 69
Table 40: Gambro AB Pipeline Products by Equipment Type 71
Table 41: Gambro AB Pipeline Products By Development Stage 72
Table 42: Gambro AB Pipeline Products By Therapy Area 72
Table 43: Gambro AB Pipeline Products By Clinical Trials 73
Table 44: Baxter International Inc. Pipeline Products by Equipment Type 76
Table 45: Baxter International Inc. Pipeline Products By Development Stage 76
Table 46: Baxter International Inc. Pipeline Products By Therapy Area 77
Table 47: Baxter International Inc. Pipeline Products By Clinical Trials 77
Table 48: Baxter International Inc. Pipeline Products By News Summary 77
Table 49: Siemens Medical Solutions Pipeline Products by Equipment Type 79
Table 50: Siemens Medical Solutions Pipeline Products By Development Stage 80
Table 51: Siemens Medical Solutions Pipeline Products By Therapy Area 80
Table 52: Siemens Medical Solutions Pipeline Products By Clinical Trials 81
Table 53: Siemens Medical Solutions Pipeline Products By News Summary 81
Table 54: C.R. Bard, Inc. Pipeline Products by Equipment Type 84
Table 55: C.R. Bard, Inc. Pipeline Products By Development Stage 84
Table 56: C.R. Bard, Inc. Pipeline Products By Therapy Area 85
Table 57: C.R. Bard, Inc. Pipeline Products By Clinical Trials 85
Table 58: Medical Enterprises Europe B.V. Pipeline Products by Equipment Type 87
Table 59: Medical Enterprises Europe B.V. Pipeline Products By Development Stage 87
Table 60: Medical Enterprises Europe B.V. Pipeline Products By Therapy Area 87
Table 61: Medical Enterprises Europe B.V. Pipeline Products By Clinical Trials 87
Table 62: USD to Local Currency, Average Exchange Rate 2008 91

Svenska Celullosa Aktiebolaget SCA
Fresenius Medical Care AG & Co. KGaA
Gambro AB
Kimberly-Clark Corporation
HARTMANN GROUP
Coloplast A/S
Baxter International Inc.
Teleflex Incorporated
STORZ MEDICAL AG
Siemens Healthcare
ONTEX International N.V.
Dornier MedTech GmbH
Covidien Ltd.
C.R. Bard, Inc.
B. Braun Melsungen AG
AstraZeneca PLC
Medical Enterprises Europe B.V.

Customers who bought this item also bought